Researchers Information System

日本語に切り替えるswitch to english

Suzuki, Tateki

Institute for Life and Medical Sciences (LiMe) Assistant Professor

Suzuki, Tateki
list
    Last Updated :2025/05/29

    Basic Information

    Affiliated programs (koza)

    • Graduate School of Pharmaceutical Sciences, 生体分子薬学, 助教

    Professional Memberships

    • From Feb. 2024
      日本蛋白質科学会
    • From 2018
      The Japanese Society for Virology

    Academic Degree

    • 修士(理学)(北海道大学)
    • 博士(生命科学)(北海道大学)

    Academic Resume (Graduate Schools)

    • 北海道大学, 大学院理学院生命理学専攻修士課程, 修了
    • 北海道大学, 大学院生命科学院生命科学専攻博士課程, 修了

    Academic Resume (Undergraduate School/Majors)

    • 北海道大学, 理学部生物科学科, 卒業

    Research History

    • From May 2021, To Present
      Kyoto University, 医生物学研究所, 助教
    • From Jul. 2018, To Apr. 2021
      九州大学大学院医学研究院, ウイルス学, 助教
    • From Oct. 2014, To Jun. 2018
      Yale University, Molecular Biophysics & Biochemistry, Postdoctoral fellow

    Language of Instruction

    • Japanese

    ID,URL

    researchmap URL

    list
      Last Updated :2025/05/29

      Research

      Research Topics, Overview of the research

      • Research Topics

        麻疹ウイルス膜融合開始複合体の構造解析による宿主細胞感染機構の解明
      • Overview of the research

        本研究は麻疹ウイルスの細胞感染メカニズムを解明することを目的とする。そのためにH-F複合体の調製を行い、X線結晶構造解析によりその立体構造を明らかにする。得られた複合体構造と既知の単独構造に基づいて構造比較を行い、膜融合制御機構仮説を立てる。その仮設に基づき、変異体ウイルスを作成し、細胞への感染実験により仮説の検証を行う。

      Research Areas

      • Life sciences, Virology
      • Life sciences, Structural biochemistry

      Papers

      • Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants.
        Yuki Anraku; Shunsuke Kita; Taishi Onodera; Akihiko Sato; Takashi Tadokoro; Shiori Ito; Yu Adachi; Ryutaro Kotaki; Tateki Suzuki; Jiei Sasaki; Nozomi Shiwa-Sudo; Naoko Iwata-Yoshikawa; Noriyo Nagata; Souta Kobayashi; Yasuhiro Kazuki; Mitsuo Oshimura; Takao Nomura; Michihito Sasaki; Yasuko Orba; Tadaki Suzuki; Hirofumi Sawa; Takao Hashiguchi; Hideo Fukuhara; Yoshimasa Takahashi; Katsumi Maenaka
        Communications biology, 22 Mar. 2025
      • Discovery of potent measles virus fusion inhibitor peptides via structure-guided derivatization.
        Ziwei Gao; Jiei Sasaki; Tateki Suzuki; Tomoaki Suzuki; Yuki Miwa; Shinsuke Sando; Takao Hashiguchi; Jumpei Morimoto
        RSC medicinal chemistry, 24 Jan. 2025
      • Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.
        Saya Moriyama; Yuki Anraku; Shunta Taminishi; Yu Adachi; Daisuke Kuroda; Shunsuke Kita; Yusuke Higuchi; Yuhei Kirita; Ryutaro Kotaki; Keisuke Tonouchi; Kohei Yumoto; Tateki Suzuki; Taiyou Someya; Hideo Fukuhara; Yudai Kuroda; Tsukasa Yamamoto; Taishi Onodera; Shuetsu Fukushi; Ken Maeda; Fukumi Nakamura-Uchiyama; Takao Hashiguchi; Atsushi Hoshino; Katsumi Maenaka; Yoshimasa Takahashi
        Nature communications, 14 Jul. 2023
      • Structural delineation of SARS-CoV-2 broadly neutralizing antibody to Omicron subvariants including BA.4/BA.5 and BA.2.75
        Saya Moriyama; Yuki Anraku; Shunta Taminishi; Yu Adachi; Daisuke Kuroda; Shunsuke Kita; Yusuke Higuchi; Ryutaro Kotaki; Keisuke Tonouchi; Kohei Yumoto; Tateki Suzuki; Taiyou Someya; Hideo Fukuhara; Yudai Kuroda; Tsukasa Yamamoto; Taishi Onodera; Shuetsu Fukushi; Ken Maeda; Fukumi Nakamura-Uchiyama; Takao Hashiguchi; Atsushi Hoshino; Katsumi Maenaka; Yoshimasa Takahashi
        21 Dec. 2022
      • Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope
        Keisuke Tonouchi; Yu Adachi; Tateki Suzuki; Daisuke Kuroda; Ayae Nishiyama; Kohei Yumoto; Haruko Takeyama; Tadaki Suzuki; Takao Hashiguchi; Yoshimasa Takahashi
        PLOS Pathogens, 09 Aug. 2023
      • Interaction of the Hemagglutinin Stalk Region with Cell Adhesion Molecule (CADM) 1 and CADM2 Mediates the Spread between Neurons and Neuropathogenicity of Measles Virus with a Hyperfusogenic Fusion Protein
        Ryuichi Takemoto; Yuichi Hirai; Shumpei Watanabe; Hidetaka Harada; Tateki Suzuki; Takao Hashiguchi; Yusuke Yanagi; Yuta Shirogane
        Journal of Virology, May 2023, Peer-reviewed
      • Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant.
        Jumpei Ito; Rigel Suzuki; Keiya Uriu; Yukari Itakura; Jiri Zahradnik; Kanako Terakado Kimura; Sayaka Deguchi; Lei Wang; Spyros Lytras; Tomokazu Tamura; Izumi Kida; Hesham Nasser; Maya Shofa; Mst Monira Begum; Masumi Tsuda; Yoshitaka Oda; Tateki Suzuki; Jiei Sasaki; Kaori Sasaki-Tabata; Shigeru Fujita; Kumiko Yoshimatsu; Hayato Ito; Naganori Nao; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Yuki Yamamoto; Tetsuharu Nagamoto; Jin Kuramochi; Gideon Schreiber; Akatsuki Saito; Keita Matsuno; Kazuo Takayama; Takao Hashiguchi; Shinya Tanaka; Takasuke Fukuhara; Terumasa Ikeda; Kei Sato
        Nature communications, 11 May 2023
      • Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
        Izumi Kimura; Daichi Yamasoba; Tomokazu Tamura; Naganori Nao; Tateki Suzuki; Yoshitaka Oda; Shuya Mitoma; Jumpei Ito; Hesham Nasser; Jiri Zahradnik; Keiya Uriu; Shigeru Fujita; Yusuke Kosugi; Lei Wang; Masumi Tsuda; Mai Kishimoto; Hayato Ito; Rigel Suzuki; Ryo Shimizu; Mst Monira Begum; Kumiko Yoshimatsu; Kanako Terakado Kimura; Jiei Sasaki; Kaori Sasaki-Tabata; Yuki Yamamoto; Tetsuharu Nagamoto; Jun Kanamune; Kouji Kobiyama; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Kotaro Shirakawa; Akifumi Takaori-Kondo; Jin Kuramochi; Gideon Schreiber; Ken J Ishii; Takao Hashiguchi; Terumasa Ikeda; Akatsuki Saito; Takasuke Fukuhara; Shinya Tanaka; Keita Matsuno; Kei Sato
        Cell, 13 Oct. 2022
      • Collective fusion activity determines neurotropism of an en bloc transmitted enveloped virus.
        Yuta Shirogane; Hidetaka Harada; Yuichi Hirai; Ryuichi Takemoto; Tateki Suzuki; Takao Hashiguchi; Yusuke Yanagi
        Science advances, 27 Jan. 2023
      • Application of Acoustic Ejection MS System to High-Throughput Screening for SARS-CoV-2 3CL Protease Inhibitors.
        Tsukasa Hasegawa; Riyo M Imamura; Tateki Suzuki; Takao Hashiguchi; Takao Nomura; Satoko Otsuguro; Katsumi Maenaka; Michihito Sasaki; Yasuko Orba; Hirofumi Sawa; Akihiko Sato; Takayoshi Okabe; Tetsuo Nagano; Hirotatsu Kojima
        Chemical & pharmaceutical bulletin, 01 Mar. 2022
      • A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site.
        Taishi Onodera; Shunsuke Kita; Yu Adachi; Saya Moriyama; Akihiko Sato; Takao Nomura; Shuhei Sakakibara; Takeshi Inoue; Takashi Tadokoro; Yuki Anraku; Kohei Yumoto; Cong Tian; Hideo Fukuhara; Michihito Sasaki; Yasuko Orba; Nozomi Shiwa; Naoko Iwata; Noriyo Nagata; Tateki Suzuki; Jiei Sasaki; Tsuyoshi Sekizuka; Keisuke Tonouchi; Lin Sun; Shuetsu Fukushi; Hiroyuki Satofuka; Yasuhiro Kazuki; Mitsuo Oshimura; Tomohiro Kurosaki; Makoto Kuroda; Yoshiharu Matsuura; Tadaki Suzuki; Hirofumi Sawa; Takao Hashiguchi; Katsumi Maenaka; Yoshimasa Takahashi
        Immunity, 12 Oct. 2021, Peer-reviewed
      • Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19.
        Yu Kaku; Takeo Kuwata; Hasan Md Zahid; Takao Hashiguchi; Takeshi Noda; Noriko Kuramoto; Shashwata Biswas; Kaho Matsumoto; Mikiko Shimizu; Yoko Kawanami; Kazuya Shimura; Chiho Onishi; Yukiko Muramoto; Tateki Suzuki; Jiei Sasaki; Yoji Nagasaki; Rumi Minami; Chihiro Motozono; Mako Toyoda; Hiroshi Takahashi; Hiroto Kishi; Kazuhiko Fujii; Tsuneyuki Tatsuke; Terumasa Ikeda; Yosuke Maeda; Takamasa Ueno; Yoshio Koyanagi; Hajime Iwagoe; Shuzo Matsushita
        Cell reports, 13 Jul. 2021
      • Short-Stalk Isoforms of CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Interacting with the Viral Hemagglutinin
        Ryuichi Takemoto; Tateki Suzuki; Takao Hashiguchi; Yusuke Yanagi; Yuta Shirogane
        Journal of Virology, 09 Feb. 2022
      • CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in cis
        Yuta Shirogane; Ryuichi Takemoto; Tateki Suzuki; Tomonori Kameda; Kinichi Nakashima; Takao Hashiguchi; Yusuke Yanagi
        Journal of Virology, 24 Jun. 2021
      • Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
        Hirofumi Ohashi; Koichi Watashi; Wakana Saso; Kaho Shionoya; Shoya Iwanami; Takatsugu Hirokawa; Tsuyoshi Shirai; Shigehiko Kanaya; Yusuke Ito; Kwang Su Kim; Takao Nomura; Tateki Suzuki; Kazane Nishioka; Shuji Ando; Keisuke Ejima; Yoshiki Koizumi; Tomohiro Tanaka; Shin Aoki; Kouji Kuramochi; Tadaki Suzuki; Takao Hashiguchi; Katsumi Maenaka; Tetsuro Matano; Masamichi Muramatsu; Masayuki Saijo; Kazuyuki Aihara; Shingo Iwami; Makoto Takeda; Jane A. McKeating; Takaji Wakita
        iScience, Apr. 2021
      • Molecular Mechanism of the Flexible Glycan Receptor Recognition by Mumps Virus
        Marie Kubota; Rei Matsuoka; Tateki Suzuki; Koji Yonekura; Yusuke Yanagi; Takao Hashiguchi
        Journal of Virology, Aug. 2019
      • A Facile Method for Producing Selenocysteine-Containing Proteins.
        Mukai T; Sevostyanova A; Suzuki T; Fu X; Söll D
        Angewandte Chemie (International ed. in English), Jun. 2018, Peer-reviewed
      • Eine einfache Methode zur Produktion von Selenoproteinen
        Mukai T; Sevostyanova A; Suzuki T; Fu X; Söll D
        Angewandte Chemie, May 2018, Peer-reviewed, Invited
      • Crystal structures reveal an elusive functional domain of pyrrolysyl-tRNA synthetase
        Tateki Suzuki; Corwin Miller; Li-Tao Guo; Joanne M. L. Ho; David Bryson; Yane-Shih Wang; David R. Liu; Dieter Soll
        NATURE CHEMICAL BIOLOGY, Dec. 2017, Peer-reviewed
      • A [3Fe-4S] cluster is required for tRNA thiolation in archaea and eukaryotes
        Yuchen Liu; David J. Vinyard; Megan E. Reesbeck; Tateki Suzuki; Kasidet Manakongtreecheep; Patrick L. Holland; Gary W. Brudvig; Dieter Soll
        PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Nov. 2016, Peer-reviewed
      • Template-dependent nucleotide addition in the reverse (3'-5') direction by Thg1-like protein
        Shoko Kimura; Tateki Suzuki; Meirong Chen; Koji Kato; Jian Yu; Akiyoshi Nakamura; Isao Tanaka; Min Yao
        SCIENCE ADVANCES, Mar. 2016, Peer-reviewed
      • Pyrrolysyl-tRNA Synthetase, an Aminoacyl-tRNA Synthetase for Genetic Code Expansion
        Ana Crnkovic; Tateki Suzuki; Dieter Soll; Noah M. Reynolds
        CROATICA CHEMICA ACTA, 2016, Peer-reviewed
      • Structure of the Pseudomonas aeruginosa transamidosome reveals unique aspects of bacterial tRNA-dependent asparagine biosynthesis
        Tateki Suzuki; Akiyoshi Nakamura; Koji Kato; Dieter Soell; Isao Tanaka; Kelly Sheppard; Min Yao
        PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Jan. 2015, Peer-reviewed
      • Human NAT10 Is an ATP-dependent RNA Acetyltransferase Responsible for N-4-Acetylcytidine Formation in 18 S Ribosomal RNA (rRNA)
        Satoshi Ito; Sayuri Horikawa; Tateki Suzuki; Hiroki Kawauchi; Yoshikazu Tanaka; Takeo Suzuki; Tsutomu Suzuki
        JOURNAL OF BIOLOGICAL CHEMISTRY, Dec. 2014, Peer-reviewed
      • Crystallization and preliminary X-ray crystallographic analysis of a bacterial Asn-transamidosome
        Tateki Suzuki; Keitaro Yamashita; Yoshikazu Tanaka; Isao Tanaka; Min Yao
        Acta Crystallographica Section F:Structural Biology Communications, 2014, Peer-reviewed
      • RNA helicase module in an acetyltransferase that modifies a specific tRNA anticodon
        Sarin Chimnaronk; Tateki Suzuki; Tetsuhiro Manita; Yoshiho Ikeuchi; Min Yao; Tsutomu Suzuki; Isao Tanaka
        EMBO JOURNAL, May 2009, Peer-reviewed

      Misc.

      • シミアンウイルス41由来hemagglutinin-neuraminidaseのX線結晶構造解析
        千葉拓実; 鈴木干城; 橋口隆生
        日本蛋白質科学会年会(Web), 2024
      • 膜融合トリガー型ヘマグルチニンストークの構造解析から考察されるモルビリウイルスの膜融合活性化メカニズム
        鈴木干城; 柳雄介; 橋口隆生
        日本分子生物学会年会プログラム・要旨集(Web), 2024
      • SARS-CoV-2BQ.1.1変異株Sタンパク質RBDによるACE2受容体認識と抗体逃避の構造基盤
        木村香菜子; 鈴木干城; 佐々木慈英; 佐藤佳; 橋口隆生
        日本蛋白質科学会年会(Web), 2024
      • Structural basis for ACE2 receptor recognition and antibody escape by SARS-CoV-2 BQ.1.1 mutant S protein RBD
        木村香菜子; 鈴木干城; 佐々木慈英; 佐藤佳; 橋口隆生
        日本ウイルス学会学術集会プログラム・予稿集(Web), 2023

      Presentations

      • Fusion-triggering structures of the morbillivirus hemagglutinin stalk provide an insight into the mechanism of fusion activation.
        鈴木 干城; 柳 雄介; 橋口 隆生
        第71回日本ウイルス学会学術集会, Nov. 2024
      • Fusion-triggering structures of the morbillivirus hemagglutinin stalk provide an insight into the mechanism of fusion activation.
        Suzuki T.; Yanagi Y.; Hashiguchi T.
        The 22nd Awaji International Forum on Infection and Immunity, Sep. 2024

      External funds: Kakenhi

      • Structural basis for the measles virus membrane fusion initiation complex
        Grant-in-Aid for Early-Career Scientists
        Basic Section 43020:Structural biochemistry-related
        Kyoto University;Kyushu University
        Tateki Suzuki
        From 01 Apr. 2019, To 31 Mar. 2024, Project Closed
        麻疹ウイルス;ヘマグルチニン;膜融合;X線結晶構造解析;構造生物学;モルビリウイルス;感染症;ウイルス;麻疹
      • 中枢神経疾患を引き起こす麻疹ウイルスによる神経細胞感染の構造基盤
        Grant-in-Aid for Early-Career Scientists
        Basic Section 43020:Structural biochemistry-related
        Kyoto University
        鈴木 干城
        From 01 Apr. 2022, To 31 Mar. 2025, Granted
        麻疹ウイルス;構造生物学;X線結晶構造解析;受容体;膜融合;SSPE
      • 受容体とがん細胞表面分子の構造共通性に着目した腫瘍溶解麻疹ウイルスの機能拡張
        Grant-in-Aid for Scientific Research (C)
        Basic Section 43040:Biophysics-related
        Kyoto University
        鈴木 干城
        From 01 Apr. 2024, To 31 Mar. 2027, Granted
        麻疹ウイルス;膜融合;腫瘍溶解ウイルス;受容体

      External funds: others

      • COVID-19治療薬シードの探索と構造基盤の解明
        上原記念生命科学財団 研究奨励金
        From 15 Feb. 2021, To 31 Mar. 2022
        鈴木干城
      • 新型コロナウイルス(SARS-CoV-2)を含む汎ベータコロナウイルス細胞侵入阻害薬の研究
        三井住友銀行 「新型コロナワクチン・治療薬開発寄付講座」寄付事業
        From 01 Oct. 2020, To 31 Mar. 2021
        鈴木干城
      list
        Last Updated :2025/05/29

        Education

        Teaching subject(s)

        • From 01 Apr. 2025, To 31 Mar. 2026
          Seminar on Critical Reading of Scientific Papers B
          8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
        • From 01 Apr. 2025, To 31 Mar. 2026
          Seminar on Critical Reading of Scientific Papers A
          8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
        • From 01 Apr. 2024, To 31 Mar. 2025
          ILAS Seminar
          Z001, Spring, Institute for Liberal Arts and Sciences, 2
        • From 01 Apr. 2024, To 31 Mar. 2025
          Research Proposal Writing Practice B
          8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
        • From 01 Apr. 2024, To 31 Mar. 2025
          Research Proposal Writing Practice A
          8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
        • From 01 Apr. 2024, To 31 Mar. 2025
          Pharmaceutical Laboratory Coaching Practice A
          8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
        • From 01 Apr. 2024, To 31 Mar. 2025
          Medicinal Frontier Science Research C
          8408, Year-long, Graduate School of Pharmaceutical Sciences, 4
        • From 01 Apr. 2024, To 31 Mar. 2025
          Medicinal Frontier Science Research B
          8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
        • From 01 Apr. 2024, To 31 Mar. 2025
          Medicinal Frontier Science Research A
          8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
        • From 01 Apr. 2024, To 31 Mar. 2025
          Seminar on Critical Reading of Scientific Papers A
          8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
        • From 01 Apr. 2024, To 31 Mar. 2025
          Seminar on Critical Reading of Scientific Papers B
          8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
        • From 01 Apr. 2023, To 31 Mar. 2024
          Research Proposal Writing Practice B
          8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
        • From 01 Apr. 2023, To 31 Mar. 2024
          Research Proposal Writing Practice A
          8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
        • From 01 Apr. 2023, To 31 Mar. 2024
          Pharmaceutical Laboratory Coaching Practice A
          8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
        • From 01 Apr. 2023, To 31 Mar. 2024
          Medicinal Frontier Science Research B
          8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
        • From 01 Apr. 2023, To 31 Mar. 2024
          Medicinal Frontier Science Research A
          8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
        • From 01 Apr. 2023, To 31 Mar. 2024
          Seminar on Critical Reading of Scientific Papers B
          8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
        • From 01 Apr. 2023, To 31 Mar. 2024
          Seminar on Critical Reading of Scientific Papers A
          8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
        • From 01 Apr. 2022, To 31 Mar. 2023
          Medical Frontier Science Research A
          8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
        • From 01 Apr. 2022, To 31 Mar. 2023
          Seminar on Critical Reading of Scientific Papers A
          8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
        • From 01 Apr. 2022, To 31 Mar. 2023
          Research Proposal Writing Practice A
          8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
        • From 01 Apr. 2022, To 31 Mar. 2023
          Pharmaceutical Laboratory Coaching Practice A
          8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
        list
          Last Updated :2025/05/29

          Administration

          Faculty management (title, position)

          • From 01 Apr. 2023
            共同利用機器等委員会 委員
          • From 01 Apr. 2022, To 31 Mar. 2023
            令和4年度医⽣物学研究所教員会議運営委員
          • From May 2021
            化学物質管理委員会 委員

          ページ上部へ戻る